Cenovus announces President & Chief Executive Officer succession

Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) today announced that as part of the company's leadership succession plan, Alex Pourbaix will shift to the role of Executive Chair and Jon McKenzie, the company's current Executive Vice-President & Chief Operating Officer, will become President & Chief Executive Officer. These changes will take effect at the conclusion of the company's annual general meeting (AGM) scheduled for April 26, 2023. At the AGM, McKenzie will be nominated for election to the Board of Directors.

"Under Alex's exceptional direction, Cenovus has transformed into a resilient, integrated energy leader. Externally, Alex goes above and beyond as a tireless advocate for the Canadian energy industry," said Keith MacPhail, Chair of the Board. "The Board has dedicated significant time to ensuring Cenovus has a strong internal succession plan and Alex has guided the development of excellent CEO candidates. We are confident that Jon's breadth of experience, together with Alex's ongoing commitment to the company, position Cenovus well to deliver on the strategy that's been established and achieve continued success."

"One of Cenovus's greatest strengths is the company's exceptionally talented people and I'm very proud of what we've been able to achieve together," said Pourbaix. "Jon – with his leadership strength, strategic vision, financial discipline, commercial acumen and knowledge of the business – is more than ready for the President & CEO role. I'm excited to continue working closely with Jon to support Cenovus and our industry as Executive Chair."

McKenzie has more than three decades of finance and operations experience, primarily in the Canadian oil and natural gas industry. He joined Cenovus in 2018 as Chief Financial Officer, and was instrumental in Cenovus's strategic merger with Husky Energy, where he served as Chief Financial Officer from 2015 to 2018.

"I am moving to this role at a time when the company is well positioned to thrive through any cycle," said McKenzie. "That's a credit to Alex's leadership and his vision for Cenovus. His decision to move to the Executive Chair role shows his dedication to the company's long-term success."

As Executive Chair, Pourbaix will be responsible for providing leadership to the Board and ensuring ongoing strong governance, while supporting management's execution of the company's strategy. Pourbaix will also remain focused on external matters relevant to Cenovus and the industry, including advancement of policy that supports a competitive Canadian energy sector and ongoing leadership with the Pathways Alliance.

After five years as a director, including three as Chair, MacPhail has decided to retire from the Cenovus Board as of this year's AGM.

"On behalf of the company and the Board of Directors, I want to thank Keith for his leadership and commitment to the Board, and our employees, communities and stakeholders," said Pourbaix. "Keith led the company through a period of significant transformation, accelerated its growth and was a key voice in developing our strategy, which we believe will support our continued success."

With Pourbaix taking on the role of Executive Chair, Claude Mongeau will assume the role of Lead Director to ensure the Board continues to operate independently. Mongeau, a Cenovus Board member since December 2016, will also be available to engage with shareholders and other key stakeholders on behalf of the Board.

"The role of Lead Director is important to ensure independence and strong corporate governance continues to be a hallmark of the Board," said MacPhail. "With Alex and Claude leading the Board, and Jon as President & CEO, the company remains well served by exemplary leaders. It has been an honour and privilege to lead this Board and I could not be prouder of the accomplishments we have delivered during my tenure."

Cenovus Energy Inc.
Cenovus Energy Inc. is an integrated energy company with oil and natural gas production operations in Canada and the Asia Pacific region, and upgrading, refining and marketing operations in Canada and the United States. The company is focused on managing its assets in a safe, innovative and cost-efficient manner, integrating environmental, social and governance considerations into its business plans. Cenovus common shares and warrants are listed on the Toronto and New York stock exchanges, and the company's preferred shares are listed on the Toronto Stock Exchange. For more information, visit cenovus.com .
Find Cenovus on Facebook , Twitter , LinkedIn , YouTube and Instagram .

Cenovus contacts

Investors Media
Investor Relations general line
403-766-7711
Media relations general line
403-766-7751


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

CVE:CA,CVE
The Conversation (0)
Helium molecules and Canada flag.

Helium Stocks: 5 Biggest Canadian Companies in 2025

Demand for helium is rising alongside the semiconductor, healthcare and nuclear energy sectors.

Produced from natural gas wells, helium is an odorless, colorless, non-toxic, non-combustible and non-corrosive gas. While it may bring to mind birthday balloons, the element is an important industrial gas due to its cooling properties.

Helium has several critical applications across various industries witnessing market growth, including the manufacturing of semiconductors and electronics, medical imaging and nuclear power generation.

Keep reading...Show less
Provaris

RaaS Research Sees Major Upside for Provaris’ Hydrogen Play

Description:

Provaris Energy’s (ASX:PV1,OTC:GBBLF) innovative hydrogen storage technology presents a compelling investment opportunity leveraging the global transition to low-carbon energy, a recent analyst report from RaaS Research Group said.

Provaris’ ‘storage tank’ IP enables greater volumes of compressed gases to be transported at lower cost, underpinning a fundamental change in the economics of the hydrogen supply chain, according to the report.

Keep reading...Show less
Westport Announces Closing of Previously Announced Light-Duty Segment Divestiture

Westport Announces Closing of Previously Announced Light-Duty Segment Divestiture

Westport Fuel Systems Inc. ("Westport" or the "Company") (TSX:WPRT Nasdaq:WPRT), today announced the successful closing of the previously announced transaction to divest its Light-Duty Segment and outlines its strategic vision for future growth, emphasizing expansion of market share, entering new markets and right sizing its current operations.

Today, Westport closed the sale of the Light-Duty Segment to a wholly-owned investment vehicle of Heliaca Investments Coöperatief U.A. ("Heliaca Investments"), a Netherlands based investment firm supported by Ramphastos Investments Management B.V., a prominent Dutch venture capital and private equity firm (the "Transaction"). The Transaction, initially announced on March 31, 2025, includes the sale of Westport Fuel Systems Italia S.r.l., encompassing the Light-Duty OEM, delayed OEM, and independent aftermarket businesses. Total consideration for the assets was a base price of approximately $79.5 million (€67.7 million), subject to certain adjustments, along with potential earnouts of up to a revised estimate of $3.9 million (€3.3 million) based on future performance milestones.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
BPH Energy Limited  Quarterly Activities Report

BPH Energy Limited Quarterly Activities Report

Perth, Australia (ABN Newswire) - Significant activities by the BPH Energy Limited (ASX:BPH) investees during the June 2025 quarter were as follows:

Advent Energy Limited ("Advent") (BPH 35.8% direct interest) PEP-11 Permit

Advent Energy Limited's100% subsidiary Asset Energy Pty Ltd ("Asset") is a participant in the PEP11 Joint Venture with partner Bounty Oil and Gas NL (ASX: BUY). PEP-11 interests are:

Advent Energy 85 % / Bounty Oil and Gas 15%

On 17 January 2025 the PEP-11 Joint Venture was given notice by NOPTA that the Joint Authority has refused the Joint Venture Applications made on 23 January 2020 and 17 March 2021 and that the PEP-11 permit would continue in force for a period of 2 months from 17 January 2025 (the "Decision").

On 12 February 2025 BPH announced that Asset had applied to the Federal Court for an Originating Application (the "Application") for judicial review pursuant to s 5 of the Administrative Decisions (Judicial Review) Act 1977 (Cth) and s 39B of the Judiciary Act 1903 (Cth) to review the Decision. The Application seeks:

1. An order quashing or setting aside the Decision;

2. A declaration that the Decision is void and of no effect; and

3. An order remitting the First Application and Second Application to the Joint Authority for reconsideration according to law.

On 17 March 2025 the Federal Court made orders by consent further set out in the Company's March 2025 Quarterly Report .

The parties have complied with all programing orders and the matter is now listed for hearing on the 16th and 17th September 2025.

There were no further developments during the June 2025 quarter.

PEP-11 continues in force and the Joint Venture is in compliance with the contractual terms of PEP11 with respect to such matters as reporting, payment of rents and the various provisions of the Offshore Petroleum and Greenhouse Gas Storage Act 2006 (Cth).

Cortical Dynamics Limited (Cortical) (BPH 16.4% direct interest)

Technical completion of Cortical's next-generation AI enhanced brain and pain monitoring BARM 2.0 is expected over the next months.

BARM 2.0 is the only solution that unifies hypnotic depth and pain response monitoring, combining EEG with AI in one system, giving clinicians real-time control over anesthesia, and hospitals a smarter, more scalable way to achieve better patient outcomes both during and after surgery.

Post technical completion BARM 2.0 clinical trials are scheduled in the USA and Netherland to be followed by submissions to regulatory authorities worldwide as soon as possible.

Cortical Dynamics was invited to showcase BARM 2.0 at the Australia Regulatory Device Summit 2025, that took place on the 17-18 July at ICC. In attendance were key stakeholders including the US FDA , Therapeutic Goods Administration (TGA) and international regulators from ANVISA (Brazil), HSA (Singapore), and PMDA (Japan). This was a unique chance for Cortical to connect directly with the regulatory community and major global players in medical technology.

Cortical has been selected to exhibit BARM 2.0 at the Medtech on the Hill at Parliament House event in Canberra 27-28 August 22025 organised by Medical Technology Association of Australia (MTAA). In attendance will be Ministers, MPs, Senators, and industry leaders for an evening networking event in Mural Hall, Parliament House. The Showcase brings together a dynamic crosssection of MTAA member companies across therapeutic areas -from Australian startups to global MedTech leaders-offering hands-on demonstrations through a curated patient journey from prevention to management, and the chance to connect directly with the people and companies driving healthcare innovation forward, as well as patients.

MTAA is the peak association representing companies in the medical technology industry. MTAA aims to ensure the benefits of modern, innovative and reliable medical technology are delivered effectively to provide better health outcomes to the Australian community.

Work continues on the development of CORDYAN(TM) which is Cortical Dynamic's new AI focussed predictive App initiative. Utilising proprietary state of the art AI and deep learning expertise Cortical Dynamics is developing game changing medical Apps that can be used in association with BARM 2.0 or standalone and /or be integrated into leading OEM healthcare systems and EMR (electronic medical records).

CORDYAN(TM)'s development has been facilitated by matched grants from MTPConnect, Australia's premier MedTech governmental organisation and ARM-hub a federal government initiative to accelerate AI related technologies in areas of strategic importance.

Clean Hydrogen Technologies (CHT) (BPH 16.2% direct interest)

As of mid-2024 CHT has developed its engineering and catalyst capabilities to a stage where it has proven consistently in its pilot plant in Nashik, India to produce its 2 products; turquoise hydrogen and a carbon composite made from majority CNT (carbon nanotubes) and CNF (carbon nanofibres), where its core process has not CO2 emissions and its feedstock is the hydrocarbons from natural gas . The next stage is to build production facilities in the USA and India, both being highly industrial markets with demand for CHT's products.

As such since mid-2024 CHT has been designing its production facility for India initially which will produce at the end of its Stage 1 build will produce 820 tonnes of hydrogen and 2,462 tonnes of carbon composite. CHT plans to sell it products to the many industrial users in the State of Maharashtra India, home of its planned production site, and likely Louisiana, USA, with several site options identified.

Before finalising production needs and CHT has been going through the ASME (required for operation in USA) and IS2825 (required for operation in India) review of its engineering designs where this process is almost complete.

CHT is now looking to source the funding required to build its plants in the USA and India where within 3-4 months of minimal funding of US$2.5m it will start producing income, initially in India and then the USA, its primary market.

*To view the full Quarterly Report, please visit:
https://abnnewswire.net/lnk/0072553O



About BPH Energy Limited:

BPH Energy Limited (ASX:BPH) is an Australian Securities Exchange listed company developing biomedical research and technologies within Australian Universities and Hospital Institutes.

The company provides early stage funding, project management and commercialisation strategies for a direct collaboration, a spin out company or to secure a license.

BPH provides funding for commercial strategies for proof of concept, research and product development, whilst the institutional partner provides infrastructure and the core scientific expertise.

BPH currently partners with several academic institutions including The Harry Perkins Institute for Medical Research and Swinburne University of Technology (SUT).



Source:
BPH Energy Limited

News Provided by ABN Newswire via QuoteMedia

Keep reading...Show less
Quarterly Activities/Appendix 4C Cash Flow Report

Quarterly Activities/Appendix 4C Cash Flow Report

BPH Energy (BPH:AU) has announced Quarterly Activities/Appendix 4C Cash Flow Report

Download the PDF here.

Latest Press Releases

Related News

×